A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate and vincristine (CEV) in previously untreated small cell lung cancer (SCLC)
Gatzemeier, U, Faderl, B, Macha, H, Kaukel, E, Deppermann, K.-M, Bonnet, R, Hessler, SVolume:
29
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(00)80090-2
Date:
September, 2000
File:
PDF, 103 KB
english, 2000